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doi: 10.1016/j.bpj.2010.01.032There is a large body of work that has attempted to elucidate
the mechanism of blood clotting from the molecular to the
physiological level, with a large focus on the large multimeric
protein von Willebrand Factor (vWF) (1–4). The overall
globular structure of vWF has been shown to unfold under
different kinds of stresses (e.g., shear stress) (2,3). Once
unfolded, the molecule can adhere to the surface of a
wounded vessel and start the formation of the plug. The un-
folding pathways of VWF are mediated through a broad
spectrum of hierarchies. In particular, it has been shown
that unfolding is intimately related to the expression of adhe-
sion proteins (5,6), flow conditions surrounding the protein
(2,7–9), and the molecular structure of vWF itself (3,4). If
the balance of these three parameters is lost, the function of
vWF is mitigated or overly enhanced, resulting in von Wille-
brand’s disease or embolism formation, respectively (9,10).
The mechanism by which vWF self-assembles with plate-
lets at the sites of vascular injury has recently received sig-
nificant attention from the polymer physics community
(2,11,12,13). A large amount of recent speculation has
focused on the ability of the overall globular structure of vWF
to unfold under the influence of shear flows, and we have
developed physical models to explain this phenomenon
(11–14). Although it appears that pure shear can induce the
blood clotting process by itself, it is worthwhile to explore
other mechanisms that might dominate under physiological
conditions. Recent work by Nesbitt et al. (7) has suggested
that shear gradients are responsible for thrombus formation,
and Zhang et al. (3) have proposed that elongational flows
could play a major role in vWF regulation. Here, we use
numerical simulations to further elaborate on this observa-
tion from a polymer physics perspective to demonstrate that
elongational flows, which naturally appear at regions with
shear gradients, are the most prominent mechanism in the
regulation of vWF, and consequently one of the primary trig-
gers in blood clotting. Interestingly, this kind of flow seemsto be ubiquitous in the blood vessel system, particularly at
locations of vasoconstriction and stenosis.
Elongational flow in a biological system is manifested
most commonly in a transition in vessel size. This is sche-
matically shown in Fig. 1, where conservation laws dictate
that the velocity in the smaller tube must be faster than in
the larger tube. In the transition from a larger tube to a smaller
tube, the fluid requires an acceleration such that locally a
suspended protein will feel an elongational pulling force as
the forward portion of the protein gets carried away at a faster
rate than the back portion (see the Supporting Material for
a more thorough treatment). The approximate rate of elonga-
tion in this case can be written as
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where v is the maximum velocity (at the center of the tube), r1
and r2 are the tube radius before and after a transition, andD is
the distance over which this radius changes. In a typical blood
vessel during injury, the process of vasoconstriction causes
the vessel to constrict to a smaller radius (15,16) (see Fig. 1
for a diagram that portrays the fluid velocity field in such
a system). This provides a way to locally induce elongation,
and as shown below, it can also induce a clotting response
with a threshold much lower than that for a constant shear rate.
Our model uses a Brownian dynamics approach to study
the dynamics of vWF in an arbitrary flow field, and takes
into account the hydrodynamic interactions between the
different units in vWF (see the Supporting Material). The
structure of vWF consists of a series of large dimers, each
consisting of a number of protein domains (10). We
FIGURE 1 A typical ﬂow proﬁle for the case of stenosis or
vasoconstriction (an approximate schematic is shown in the
center-top-right area). The entry to such a blockage results in
elongational ﬂow (see the Supporting Material for discussion).
On the top, there is a graph of both the ﬂuid velocity and the
velocity gradient (or elongational ﬂow rate 3) along the center
of the tube. The maximum elongational rate clearly occurs in
the transition region between the different radii (that are bounded
by D) and tends toward zero in the regimes where the vessel
radius remains constant. The bottom right shows the effect
of placing a protein (the red globule) in this sort of ﬂow: in the
transition region d, the protein is elongated by the ﬂow ﬁeld.
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are connected by springlike forces. The hydrophobic interac-
tions and self-association between dimers are represented
by an effective interaction energy between two different
beads Du, which collapses the protein into a dense globule.
This type of simulation has been used for simple shear
flow in previous works that elucidated the mechanism for
unfolding of collapsed globules in shear flow (11,12).
Following the coordinate system employed in Fig. 1, the
flow field to which a molecule is exposed (in the reference
frame of the molecule itself) while passing through the tran-
sition region D is well approximated by (see the Supporting
Material for a detailed analysis)
~v ¼ _e
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
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where bex;y;z is the unit vector in the corresponding Cartesian
coordinate direction and _e is the elongation rate. Diagrams
of the flow field and a typical unfolding polymer from the
simulations are shown in Fig. 2 a. Fig. 2 b represents the
behavior of a vWF-type polymer by considering the mean
extension versus the elongation rate _e. This demonstratesBiophysical Journal 98(9) L35–L37that there is a critical flow rate at which the globule (Fig. 2 a,
far-left conformation) unfolds to a fully extended chain
(Fig. 2 a, far-right conformation). We also include unfolding
as a function of shear rate _g, and obtain results similar to
previous studies on vWF in shear flows (11,12). There are
striking differences between the two data sets, most noticeably
in that the shear case demonstrates a much broader transition
at rates two orders-of-magnitude larger than the elongation
case. The dynamics of the two cases suggest that these differ-
ences are due to the rotational nature of shear flow—the exten-
sion of polymers in shear is ultimately limited by what is
known as tumbling behavior, which causes the globule to
continuously transition between collapsed and stretched states
(17). Furthermore, the regulation of vWF is believed to be
force-dependent, and we show in Fig. 2 c for mixed elonga-
tion-shear flows that the globule-stretch transition does induce
a large change in the maximum tensile force along the chain.
However, this figure again emphasizes the differences
between elongation and shear, with the former displaying
a large, discrete jump in tensile force per monomer while
the latter shows a much more broad and continuous increase
at rates two orders-of-magnitude above pure elongation.
The physical model presented above can be directly trans-
lated to the case of vWF in the bloodstream by considering
typical parameters for the collapsed globule. If we consider
a monomer size of ~50 nm (a typical vWF dimer size), an effec-
tive interaction energy ofDu ~ 0.5 – 1.5 kT (the typical strength
of van der Waals/hydrophobic type interactions), and room
temperature T ~300 K, we obtain critical flow rates of
_ec  3  102  6  102 s1. To compare this flow rate to
what would be found in a typical blood flow, we consider the
model described by Eq. 1. Assuming a change in radius of
~20%, a typical preconstriction blood velocity in the microcir-
culation of ~0.1 m/s, and D ~10 mm, the typical elongation rate
is _e  5:6  103 s1, which is an order-of-magnitude beyond
the critical rate at which the unfolding process will occur. Alter-
natively, significant amplification of the vWF response and
platelet aggregation upon stenosis was seen in the work by Nes-
bitt et al. (7). The values utilized in that work indicate that an
elongation rate of ~2  104 s1 was more than sufficient to
induce thrombus formation (7). Both results are well above
the simulated threshold for elongational induced vWF stretch-
ing, and indicate that the application of an elongational flow is
a strong regulator vWF activation. For comparison, simulations
place the pure shear flow-induced stretching transition near 104
s1 (see Fig. 2 b), which is in the uppermost side in our circu-
latory system, perhaps only occurring during stenosis. Hence,
pure shear requires a much more exclusive set of conditions
than elongational flow (7).
Our results indicate that the unfolding of vWF in the
bloodstream before clotting is regulated very strongly by
elongational flow fields, particularly compared to shear
flow, which is weaker by two orders-of-magnitude and
does not demonstrate the necessary sharp transition that
would mediate the on-off biological functionality required
FIGURE 2 (a) The elongational ﬂow (proﬁle shown: z is the
stretching axis as per Eq. 2 and Fig. 1, whereas x is an arbitrary
transverse axis) imposed on a collapsed vWF molecule has the
ability to stretch the protein. This opens up the quaternary struc-
ture to allow for bonding with other molecules. The snapshots
shown represent the unfolding over time seen in simulations of
vWF in elongational ﬂow. (b) The average percent extension of
vWF as a function of the elongation/shear rate _e= _g for simulation
using two different interaction energies Du and a dimer size of
~50 nm (see text for discussion). (c) The maximum tensile force
along thechainFmappedasa functionof elongationversusshear
rates (u ¼ 1.5 kT). We note that this maximum, for an extended
chain, occurs at the center of the chain as predicted in Zhang
et al. (3). This forcequickly increases into the biologically relevant
regime as elongational ﬂow is applied, whereas application of
shear ﬂow demonstrates a much more broad transition.
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ular level, because it has been shown that the vWF binding is
strongly dependent on the application of strong forces along
the protein chain (8). Our results also agree quantitatively
with the maximum tensile force per monomer necessary to
cleave vWF by ADAMTS13 determined by Zhang et al.
(3), with the maximum force along the chain exceeding
~10 pN upon unfolding in an elongational flow.
The results presented here provide a further understanding
of the dynamics of VWF and could be translated into the
development of treatments for a wide variety of diseases asso-
ciated with blood clotting, such as von Willebrand’s disease,
ischemic stroke, and acute coronary syndromes. In addition,
these results provide insights into other somewhat counterin-
tuitive diseases such as Heyde’s syndrome, in which arterial
stenosis induces clotting disorders. Clearly, by having an
stenotic vessel, the activation of vWF becomes prominent
due to the strong elongational component that appears in the
flow, inducing either complexation of vWF with platelets to
promote a local thrombotic thrombocytopenic purpura, or itgets degraded by ADAMTS13 and becomes nonfunctional.
Both of these processes lead to bleeding, as observed. In
summary, we have presented a convincing case that implies
that elongational flow under pathophysiological conditions
strongly supplements shear flow, and could be the main
mechanism to induce unfolding and activation of vWF. These
findings represent a new paradigm in the function of vWF.
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